4//SEC Filing
Satlin Andrew 4
Accession 0001209191-19-003261
CIK 0001567514other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:28 PM ET
Size
8.0 KB
Accession
0001209191-19-003261
Insider Transaction Report
Form 4
Satlin Andrew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-08+94,443→ 94,443 totalExercise: $12.73Exp: 2029-01-07→ Common Stock (94,443 underlying) - Award
Restricted Stock Units
2019-01-08+68,735→ 68,735 total→ Common Stock (68,735 underlying)
Footnotes (3)
- [F1]On January 8, 2019, the reporting person was granted options to purchase 94,443 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On January 8, 2019, the reporting person was granted 68,735 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001722858
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:28 PM ET
- Size
- 8.0 KB